Masimo (NSDQ:MASI) said today it won CE Mark approval in the European Union for its RPVi, a multi-wavelength version of the currently available Pleth Variability Index designed to provide enhanced specificity to changes in fluid volume compared to PVi.
The Irvine, Calif.-based company said that the RPVi is a noninvasive, continuous measurement designed to show dynamic changes in perfusion index that occur during respiratory cycles, which can reflect physiologic factors including vascular tone, circulating blood volume and intrathoracic pressure excursions.
“Masimo rainbow technology, first announced in 2005, continues to drive innovative new measurements and improvements to existing ones. We are proud to introduce RPVi, and hope that it will be useful to clinicians around the world in helping to improve patient care,” CEO Joe Kiani said in a press release.
Last week, Masimo said it won CE Mark approval for its Rainbow Super DCI-mini sensor designed as a reusable spot-check sensor with multiple physiologic measurements.